Related references
Note: Only part of the references are listed.Design, synthesis and biological evaluation of novel 1H-1,2,4-triazole, benzothiazole and indazole-based derivatives as potent FGFR1 inhibitors viafragment-based virtual screening
Jian Liu et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2020)
Design, synthesis and 3D-QSAR analysis of novel thiopyranopyrimidine derivatives as potential antitumor agents inhibiting A549 and Hela cancer cells
Bingbing Zhao et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Synthesis, and anti-proliferative, Pim-1 kinase inhibitors and molecular docking of thiophenes derived from estrone
Rafat M. Mohareb et al.
BIOORGANIC CHEMISTRY (2019)
Modulating Protein-Protein Interactions with Visible-Light-Responsive Peptide Backbone Photoswitches
Lea Albert et al.
CHEMBIOCHEM (2019)
In silico drug design of inhibitor of nuclear factor kappa B kinase subunit beta inhibitors from 2-acylamino-3-aminothienopyridines based on quantitative structure-activity relationships and molecular docking
Jiao-Long Wang et al.
COMPUTATIONAL BIOLOGY AND CHEMISTRY (2019)
Allosteric Modulator Discovery: From Serendipity to Structure-Based Design
Shaoyong Lu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Properties of FDA-approved small molecule protein kinase inhibitors
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2019)
Defining a new nomenclature for the structures of active and inactive kinases
Vivek Modi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
An Overview of Scoring Functions Used for Protein-Ligand Interactions in Molecular Docking
Jin Li et al.
INTERDISCIPLINARY SCIENCES-COMPUTATIONAL LIFE SCIENCES (2019)
Synthesis, anticancer effect and molecular modeling of new thiazolylpyrazolyl coumarin derivatives targeting VEGFR-2 kinase and inducing cell cycle arrest and apoptosis
Tahia K. Mohamed et al.
BIOORGANIC CHEMISTRY (2019)
Structure-Based Design, Synthesis, and Biological Evaluation of Imidazo[4,5-b]pyridin-2-one-Based p38 MAP Kinase Inhibitors: Part 1
Akira Kaieda et al.
CHEMMEDCHEM (2019)
Preclinical Characteristics of the Irreversible Pan-HER Kinase Inhibitor Neratinib Compared with Lapatinib: Implications for the Treatment of HER2-Positive and HER2-Mutated Breast Cancer
Denis M. Collins et al.
CANCERS (2019)
Kinase Atlas: Druggability Analysis of Potential Allosteric Sites in Kinases
Christine Yueh et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Molecular dynamics investigation on the Asciminib resistance mechanism of I502L and V468F mutations in BCR-ABL
Jiu-Yu Zhan et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2019)
In Silico Reoptimization of Binding Affinity and Drug-Resistance Circumvention Ability in Kinase Inhibitors: A Case Study with RL-45 and Src Kinase
Jaya Krishna Koneru et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2019)
Rational discovery of dual-indication multi-target PDE/Kinase inhibitor for precision anti-cancer therapy using structural systems pharmacology
Hansaim Lim et al.
PLOS COMPUTATIONAL BIOLOGY (2019)
DeepConv-DTI: Prediction of drug-target interactions via deep learning with convolution on protein sequences
Ingo Lee et al.
PLOS COMPUTATIONAL BIOLOGY (2019)
Combination of Immunotherapy With Targeted Therapy: Theory and Practice in Metastatic Melanoma
Chune Yu et al.
FRONTIERS IN IMMUNOLOGY (2019)
3D-QSAR pharmacophore modelling, virtual screening and docking studies for lead discovery of a novel scaffold for VEGFR 2 inhibitors: Design, synthesis and biological evaluation
Mahitab K. Sobhy et al.
BIOORGANIC CHEMISTRY (2019)
Rational Drug Design of Antineoplastic Agents Using 3D-QSAR, Cheminformatic, and Virtual Screening Approaches
Jelica Vucicevic et al.
CURRENT MEDICINAL CHEMISTRY (2019)
Reaction-Based Enumeration, Active Learning, and Free Energy Calculations To Rapidly Explore Synthetically Tractable Chemical Space and Optimize Potency of Cyclin-Dependent Kinase 2 Inhibitors
Kyle D. Konze et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2019)
Enhanced sampling in molecular dynamics
Yi Isaac Yang et al.
JOURNAL OF CHEMICAL PHYSICS (2019)
Insights into the EGFR SAR of N-phenylquinazolin-4-amine-derivatives using quantum mechanical pairwise-interaction energies
Saw Simeon et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2019)
Deep learning enables rapid identification of potent DDR1 kinase inhibitors
Alex Zhavoronkov et al.
NATURE BIOTECHNOLOGY (2019)
Discovery of a novel protein kinase C activator from Croton tiglium for inhibition of non-small cell lung cancer
Wang Yuwei et al.
PHYTOMEDICINE (2019)
Design, Synthesis and Preliminary Biological Evaluation of Benzylsulfone Coumarin Derivatives as Anti-Cancer Agents
Tao Wang et al.
MOLECULES (2019)
Multi-Target Chemometric Modelling, Fragment Analysis and Virtual Screening with ERK Inhibitors as Potential Anticancer Agents
Amit Kumar Halder et al.
MOLECULES (2019)
Discovery of arylamide-5-anilinoquinazoline-8-nitro derivatives as VEGFR-2 kinase inhibitors: Synthesis, in vitro biological evaluation and molecular docking
Yongqiang Zhao et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
Computer-aided design, synthesis and biological characterization of novel inhibitors for PKMYT1
Abdulkarim Najjar et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Synthesis, molecular modeling and anti-cancer evaluation of a series of quinazoline derivatives
Ahmed Khodair et al.
CARBOHYDRATE RESEARCH (2019)
In silico design, synthesis and activity of potential drug-like chrysin scaffoldd-erived selective EGFR inhibitors as anticancer agents
Sudhan Debnath et al.
COMPUTATIONAL BIOLOGY AND CHEMISTRY (2019)
Predictive models for designing potent tyrosine kinase inhibitors in chronic myeloid leukemia for understanding its molecular mechanism of resistance by molecular docking and dynamics simulations
Anu R. Melge et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2019)
Combined Ligand and Fragment-based Drug Design of Selective Histone Deacetylase-6 Inhibitors
Dusan Ruzic et al.
MOLECULAR INFORMATICS (2019)
PubChem 2019 update: improved access to chemical data
Sunghwan Kim et al.
NUCLEIC ACIDS RESEARCH (2019)
ChEMBL: towards direct deposition of bioassay data
David Mendez et al.
NUCLEIC ACIDS RESEARCH (2019)
Cyclin-dependent protein serine/threonine kinase inhibitors as anticancer drugs
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2019)
Leveraging Image-Derived Phenotypic Measurements for Drug-Target Interaction Predictions
Srikanth Kuthuru et al.
CANCER INFORMATICS (2019)
DFT-based reactivity and combined QSAR, molecular docking of 1,2,4,5-Tetrazine derivatives as inhibitors of Pim-1 kinase
Halima Hazhazi et al.
HELIYON (2019)
Ligand- and structure-based pharmacophore modeling, docking study reveals 2-[[4-[6-(isopropylamino) pyrimidin-4-yl]-1H-pyrrolo[2,3-b] pyridin-6-yl] amino] ethanol as a potential anticancer agent of CDK9/cyclin T1 kinase
Afzal Hussain et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2019)
DrugBank 5.0: a major update to the DrugBank database for 2018
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2018)
Identification of PKMYT1 inhibitors by screening the GSK published protein kinase inhibitor set I and II
Charlott Platzer et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
Dual Drug Targeting of Mutant Bcr-Abl Induces Inactive Conformation: New Strategy for the Treatment of Chronic Myeloid Leukemia and Overcoming Monotherapy Resistance
Ahmed A. El Rashedy et al.
CHEMISTRY & BIODIVERSITY (2018)
Structure-based prediction of protein allostery
Joe G. Greener et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2018)
Discovery of hidden allosteric sites as novel targets for allosteric drug design
Shaoyong Lu et al.
DRUG DISCOVERY TODAY (2018)
Reinforced Adversarial Neural Computer for de Novo Molecular Design
Evgeny Putin et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2018)
Predicting the Conformational Variability of Abl Tyrosine Kinase using Molecular Dynamics Simulations and Markov State Models
Yilin Meng et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2018)
Optimization of Selective Mitogen-Activated Protein Kinase Interacting Kinases 1 and 2 Inhibitors for the Treatment of Blast Crisis Leukemia
Haiyan Yang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Kinase-targeted cancer therapies: progress, challenges and future directions
Khushwant S. Bhullar et al.
MOLECULAR CANCER (2018)
De Novo Design of Bioactive Small Molecules by Artificial Intelligence
Daniel Merk et al.
MOLECULAR INFORMATICS (2018)
PKIDB: A Curated, Annotated and Updated Database of Protein Kinase Inhibitors in Clinical Trials
Fabrice Carles et al.
MOLECULES (2018)
CavityPlus: a web server for protein cavity detection with pharmacophore modelling, allosteric site identification and covalent ligand binding ability prediction
Youjun Xu et al.
NUCLEIC ACIDS RESEARCH (2018)
AlloFinder: a strategy for allosteric modulator discovery and allosterome analyses
Min Huang et al.
NUCLEIC ACIDS RESEARCH (2018)
The oncogenic tyrosine kinase Lyn impairs the pro-apoptotic function of Bim
Lazaro E. Aira et al.
ONCOGENE (2018)
Markov models for the elucidation of allosteric regulation
Ushnish Sengupta et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2018)
Computer-Aided Drug Design in Epigenetics
Wenchao Lu et al.
FRONTIERS IN CHEMISTRY (2018)
Discovery of Asciminib (ABL001), an Allosteric Inhibitor of the Tyrosine Kinase Activity of BCR-ABL1
Joseph Schoepfer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Design, Synthesis and Docking Studies of Novel Macrocyclic Pentapeptides as Anticancer Multi-Targeted Kinase Inhibitors
Abd El-Galil E. Amr et al.
MOLECULES (2018)
A review of ligand-based virtual screening web tools and screening algorithms in large molecular databases in the age of big data
Antonio-Jesus Banegas-Luna et al.
FUTURE MEDICINAL CHEMISTRY (2018)
Studies on the Dual Activity of EGFR and HER-2 Inhibitors Using Structure-Based Drug Design Techniques
Rafaela Molina de Angelo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Combining a QSAR Approach and Structural Analysis to Derive an SAR Map of Lyn Kinase Inhibition
Imane Naboulsi et al.
MOLECULES (2018)
Molecular Modeling and Design Studies of Purine Derivatives as Novel CDK2 Inhibitors
Gaomin Zhang et al.
MOLECULES (2018)
QSAR-Based Virtual Screening: Advances and Applications in Drug Discovery
Bruno J. Neves et al.
FRONTIERS IN PHARMACOLOGY (2018)
Redefining the Protein Kinase Conformational Space with Machine Learning
Peter Man-Un Ung et al.
CELL CHEMICAL BIOLOGY (2018)
Profiling Prediction of Kinase Inhibitors: Toward the Virtual Assay
Benjamin Merget et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Examining the influence of specificity ligands and ATP-competitive ligands on the overall effectiveness of bivalent kinase inhibitors
Margaret L. Wong et al.
PROTEOME SCIENCE (2017)
Statistical Analysis and Prediction of Covalent Ligand Targeted Cysteine Residues
Weilin Zhang et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2017)
Improved Method for the Identification and Validation of Allosteric Sites
Kun Song et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2017)
Discovery of novel dual inhibitors of receptor tyrosine kinases EGFR and PDGFR-β related to anticancer drug resistance
Tim Fischer et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2017)
The target landscape of clinical kinase drugs
Susan Klaeger et al.
SCIENCE (2017)
Design, Synthesis, and Evaluation of Ribose-Modified Anilinopyrimidine Derivatives as EGFR Tyrosine Kinase Inhibitors
Xiuqin Hu et al.
FRONTIERS IN CHEMISTRY (2017)
Progress towards a public chemogenomic set for protein kinases and a call for contributions
David H. Drewry et al.
PLOS ONE (2017)
Probing the Binding Mechanism of Mnk Inhibitors by Docking and Molecular Dynamics Simulations (vol 54, pg 32, 2015)
Srinivasaraghavan Kannan et al.
BIOCHEMISTRY (2017)
3D-QSAR, Virtual Screening, Docking and Design of Dual PI3K/mTOR Inhibitors with Enhanced Antiproliferative Activity
Jelena Oluic et al.
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2017)
3D-QSAR studies and pharmacophore identification of AT1 receptor antagonists
Miralem Smajic et al.
MEDICINAL CHEMISTRY RESEARCH (2016)
Alloscore: a method for predicting allosteric ligand-protein interactions
Shuai Li et al.
BIOINFORMATICS (2016)
A combined ligand- and structure-based approach for the identification of rilmenidine-derived compounds which synergize the antitumor effects of doxorubicin
Jelica Vucicevic et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Protein Allostery and Conformational Dynamics
Jingjing Guo et al.
CHEMICAL REVIEWS (2016)
Emerging Computational Methods for the Rational Discovery of Allosteric Drugs
Jeffrey R. Wagner et al.
CHEMICAL REVIEWS (2016)
Discovery of Non-ATP-Competitive Inhibitors of Polo-like Kinase1
Taikangxiang Yun et al.
CHEMMEDCHEM (2016)
Synthesis of the vitamin E amino acid esters with an enhanced anticancer activity and in silico screening for new antineoplastic drugs
Zarko Gagic et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
Advanced molecular dynamics simulation methods for kinase drug discovery
Samia Aci-Seche et al.
FUTURE MEDICINAL CHEMISTRY (2016)
Unprecedently Large-Scale Kinase Inhibitor Set Enabling the Accurate Prediction of Compound-Kinase Activities: A Way toward Selective Promiscuity by Design?
Serge Christmann-Franck et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2016)
Motions of Allosteric and Orthosteric Ligand-Binding Sites in Proteins are Highly Correlated
Xiaomin Ma et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2016)
HRD Motif as the Central Hub of the Signaling Network for Activation Loop Autophosphorylation in Abl Kinase
Giuseppina La Sala et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2016)
QSAR studies and design of new analogs of vitamin E with enhanced antiproliferative activity on MCF-7 breast cancer cells
Zarko Gagic et al.
JOURNAL OF THE TAIWAN INSTITUTE OF CHEMICAL ENGINEERS (2016)
The Next Era: Deep Learning in Pharmaceutical Research
Sean Ekins
PHARMACEUTICAL RESEARCH (2016)
Classification of small molecule protein kinase inhibitors based upon the structures of their drug-enzyme complexes
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2016)
Predictive proteochemometric models for kinases derived from 3D protein field-based descriptors
Vigneshwari Subramanian et al.
MEDCHEMCOMM (2016)
Alignment independent 3D-QSAR, quantum calculations and molecular docking of Mer specific tyrosine kinase inhibitors as anticancer drugs
Fereshteh Shiri et al.
SAUDI PHARMACEUTICAL JOURNAL (2016)
Identification of a Novel Inhibitory Allosteric Site in p38α
Patricia Gomez-Gutierrez et al.
PLoS One (2016)
Bidirectional Allosteric Communication between the ATP-Binding Site and the Regulatory PIF Pocket in PDK1 Protein Kinase
Joerg O. Schulze et al.
CELL CHEMICAL BIOLOGY (2016)
Mnks, eIF4E phosphorylation and cancer
Christopher G. Proud
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2015)
The ABC of protein kinase conformations
Henrik Moebitz
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2015)
Tumor Progression Locus 2 (Tpl2) Kinase as a Novel Therapeutic Target for Cancer: Double-Sided Effects of Tpl2 on Cancer
Hye Won Lee et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Combinatorial Pharmacophore-Based 3D-QSAR Analysis and Virtual Screening of FGFR1 Inhibitors
Nannan Zhou et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Classification of Current Scoring Functions
Jie Liu et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2015)
Small-Molecule Allosteric Modulators of the Protein Kinase PDK1 from Structure-Based Docking
T. Justin Rettenmaier et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Pharmacophore modeling, drug design and virtual screening on multi-targeting procognitive agents approaching histaminergic pathways
Katarina Nikolic et al.
JOURNAL OF THE TAIWAN INSTITUTE OF CHEMICAL ENGINEERS (2015)
Virtual screening strategies: Recent advances in the identification and design of anti-cancer agents
Vikash Kumar et al.
METHODS (2015)
Molecular Docking and Structure-Based Drug Design Strategies
Leonardo G. Ferreira et al.
MOLECULES (2015)
The FTMap family of web servers for determining and characterizing ligand-binding hot spots of proteins
Dima Kozakov et al.
NATURE PROTOCOLS (2015)
Structure and mechanism of activity-based inhibition of the EGF receptor by Mig6
Eunyoung Park et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)
A historical overview of protein kinases and their targeted small molecule inhibitors
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2015)
Allosteric small-molecule kinase inhibitors
Peng Wu et al.
PHARMACOLOGY & THERAPEUTICS (2015)
FDA-approved small-molecule kinase inhibitors
Peng Wu et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Why is Tanimoto index an appropriate choice for fingerprint-based similarity calculations?
David Bajusz et al.
JOURNAL OF CHEMINFORMATICS (2015)
Structure and mechanism of activity-based inhibition of the EGF receptor by Mig6
Eunyoung Park et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)
Exploring a Non-ATP Pocket for Potential Allosteric Modulation of PI3Kα
Paraskevi Gkeka et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2015)
Exploration of potential EGFR inhibitors: a combination of pharmacophore-based virtual screening, atom-based 3D-QSAR and molecular docking analysis
Arumugam Sudha et al.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2015)
Evolution and intelligent design in drug development
Roman V. Agafonov et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2015)
Drugs for Allosteric Sites on Receptors
Cody J. Wenthur et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 54 (2014)
Structure-based discovery of the first allosteric inhibitors of cyclin-dependent kinase 2
Giulio Rastelli et al.
CELL CYCLE (2014)
Assessing the accuracy of physical models used in protein-folding simulations: quantitative evidence from long molecular dynamics simulations
Stefano Piana et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2014)
Protein-Protein Interface Analysis and Hot Spots Identification for Chemical Ligand Design
Jing Chen et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Molecular Mechanics
Kenno Vanommeslaeghe et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Structure-Based Virtual Screening for Drug Discovery: Principles, Applications and Recent Advances
Evanthia Lionta et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2014)
Design, synthesis, pharmacological evaluation, QSAR analysis, molecular modeling and ADMET of novel donepezil-indolyl hybrids as multipotent cholinesterase/monoamine oxidase inhibitors for the potential treatment of Alzheimer's disease
Oscar M. Bautista-Aguilera et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
QSAR Modeling: Where Have You Been? Where Are You Going To?
Artem Cherkasov et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
In silico screening and study of novel ERK2 inhibitors using 3D QSAR, docking and molecular dynamics
Sofiene Larif et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2014)
Chemical con artists foil drug discovery
Jonathan Baell et al.
NATURE (2014)
Activation pathway of Src kinase reveals intermediate states as targets for drug design
Diwakar Shukla et al.
NATURE COMMUNICATIONS (2014)
Strategies for the Selective Regulation of Kinases with Allosteric Modulators: Exploiting Exclusive Structural Features
Zhizhou Fang et al.
ACS CHEMICAL BIOLOGY (2013)
Imidazoline-1 Receptor Ligands as Apoptotic Agents: Pharmacophore Modeling and Virtual Docking Study
Katarina Nikolic et al.
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2013)
Binding Site Detection and Druggability Prediction of Protein Targets for Structure-Based Drug Design
Yaxia Yuan et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Structure-based Discovery of Antagonists of Nuclear Receptor LRH-1
Cindy Benod et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Visually Interpretable Models of Kinase Selectivity Related Features Derived from Field-Based Proteochemometrics
Vigneshwari Subrarnanian et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2013)
Through the open door: Preferential binding of dasatinib to the active form of BCR-ABL unveiled by in silico experiments
Erik Laurini et al.
MOLECULAR ONCOLOGY (2013)
Activation of Jak2 in patients with blast crisis chronic myelogenous leukemia: inhibition of Jak2 inactivates Lyn kinase
S. Chakraborty et al.
BLOOD CANCER JOURNAL (2013)
A comparative QSAR analysis and molecular docking studies of quinazoline derivatives as tyrosine kinase (EGFR) inhibitors: A rational approach to anticancer drug design
Malleshappa N. Noolvi et al.
JOURNAL OF SAUDI CHEMICAL SOCIETY (2013)
Cancer drug resistance: an evolving paradigm
Caitriona Holohan et al.
NATURE REVIEWS CANCER (2013)
Biomolecular Simulation: A Computational Microscope for Molecular Biology
Ron O. Dror et al.
ANNUAL REVIEW OF BIOPHYSICS, VOL 41 (2012)
Discovery of 4-morpholino-pyrimidin-6-one and 4-morpholino-pyrimidin-2-one-containing Phosphoinositide 3-kinase (PI3K) p110β isoform inhibitors through structure-based fragment optimisation
Fabrizio Giordanetto et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
The rise and fall of gatekeeper mutations? The BCR-ABL1 T315I paradigm
Don L. Gibbons et al.
CANCER (2012)
A Novel Approach to the Discovery of Small-Molecule Ligands of CDK2
Mathew P. Martin et al.
CHEMBIOCHEM (2012)
Molecular Dynamics of Protein Kinase-Inhibitor Complexes: A Valid Structural Information
Julio Caballero et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
New Directions in Targeting Protein Kinases: Focusing Upon True Allosteric and Bivalent Inhibitors
Vandana Lamba et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Tyrosine kinase inhibitor (TKI)-induced cardiotoxicity: approaches to narrow the gaps between preclinical safety evaluation and clinical outcome
Baichun Yang et al.
JOURNAL OF APPLIED TOXICOLOGY (2012)
ZINC: A Free Tool to Discover Chemistry for Biology
John J. Irwin et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2012)
Are Protein Force Fields Getting Better? A Systematic Benchmark on 524 Diverse NMR Measurements
Kyle A. Beauchamp et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2012)
Pharmacophore generation and atom-based 3D-QSAR of novel quinoline-3-carbonitrile derivatives as Tpl2 kinase inhibitors
Mahesh Kumar Teli et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2012)
Toward understanding the molecular basis for chemical allosteric modulator design
Qi Wang et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2012)
Vemurafenib: the first drug approved for BRAF-mutant cancer
Gideon Bollag et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations
Keith T. Flaherty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
MKNK1 is a YB-1 target gene responsible for imparting trastuzumab resistance and can be blocked by RSK inhibition
A. Astanehe et al.
ONCOGENE (2012)
Refinement of protein structure homology models via long, all-atom molecular dynamics simulations
Alpan Raval et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2012)
Discovery of a Novel Chemotype of Tyrosine Kinase Inhibitors by Fragment-Based Docking and Molecular Dynamics
Hongtao Zhao et al.
ACS MEDICINAL CHEMISTRY LETTERS (2012)
Discovery of a Potential Allosteric Ligand Binding Site in CDK2
Stephane Betzi et al.
ACS CHEMICAL BIOLOGY (2011)
The Evolution of Protein Kinase Inhibitors from Antagonists to Agonists of Cellular Signaling
Arvin C. Dar et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 80 (2011)
Discovery of novel class 1 phosphatidylinositide 3-kinases (PI3K) fragment inhibitors through structure-based virtual screening
Fabrizio Giordanetto et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Molecular complexity and fragment-based drug discovery: ten years on
Andrew R. Leach et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2011)
Discovery of Novel Pim-1 Kinase Inhibitors by a Hierarchical Multistage Virtual Screening Approach Based on SVM Model, Pharmacophore, and Molecular Docking
Ji-Xia Ren et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2011)
Fragment-based lead discovery: challenges and opportunities
Chaohong Sun et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2011)
Dasatinib preferentially induces apoptosis by inhibiting Lyn kinase in nilotinib-resistant chronic myeloid leukemia cell line
Seiichi Okabe et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2011)
Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes
Thomas Force et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Protein kinases: evolution of dynamic regulatory proteins
Susan S. Taylor et al.
TRENDS IN BIOCHEMICAL SCIENCES (2011)
Predicting a small molecule-kinase interaction map: A machine learning approach
Fabian Buchwald et al.
JOURNAL OF CHEMINFORMATICS (2011)
The rational design of a novel potent analogue of the 5′-AMP-activated protein kinase inhibitor compound C with improved selectivity and cellular activity
Fouzia Machrouhi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Software News and Update AutoDock Vina: Improving the Speed and Accuracy of Docking with a New Scoring Function, Efficient Optimization, and Multithreading
Oleg Trott et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2010)
Discovery of Mitogen-Activated Protein Kinase-Interacting Kinase 1 Inhibitors by a Comprehensive Fragment-Oriented Virtual Screening Approach
Julen Oyarzabal et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Through the Gatekeeper Door: Exploiting the Active Kinase Conformation
Fabio Zuccotto et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Binding or Bending: Distinction of Allosteric Abl Kinase Agonists from Antagonists by an NMR-Based Conformational Assay
Wolfgang Jahnke et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
The cardiotoxicity and myocyte damage caused by small molecule anticancer tyrosine kinase inhibitors is correlated with lack of target specificity
Brian B. Hasinoff
TOXICOLOGY AND APPLIED PHARMACOLOGY (2010)
Characterization of the CHK1 Allosteric Inhibitor Binding Site
Darin Vanderpool et al.
BIOCHEMISTRY (2009)
Identification of pyrazolo[1,5-a]pyrimidine-3-carboxylates as B-Raf kinase inhibitors
Ariamala Gopalsamy et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Fpocket: An open source platform for ligand pocket detection
Vincent Le Guilloux et al.
BMC BIOINFORMATICS (2009)
Long-timescale molecular dynamics simulations of protein structure and function
John L. Klepeis et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2009)
Suitability of GRIND-Based Principal Properties for the Description of Molecular Similarity and Ligand-Based Virtual Screening
Angel Duran et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2009)
AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility
Garrett M. Morris et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2009)
Prediction of drug-target interaction networks from the integration of chemical and genomic spaces
Yoshihiro Yamanishi et al.
BIOINFORMATICS (2008)
Discovery of 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methylbenzenesulfonamide (pazopanib), a novel and potent vascular endothelial growth factor receptor inhibitor
Philip A. Harris et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
4-(phenylaminomethylene)isoquinoline-1,3(2H,4H)-diones as potent and selective inhibitors of the cyclin-dependent kinase 4 (CDK4)
Hwei-Ru Tsou et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
ChemBank: a small-molecule screening and cheminformatics resource database
Kathleen Petri Seiler et al.
NUCLEIC ACIDS RESEARCH (2008)
Dissecting eIF4E action in tumorigenesis
Hans-Guido Wendel et al.
GENES & DEVELOPMENT (2007)
Conservation, Variability and the Modeling of Active Protein Kinases
James D. R. Knight et al.
PLOS ONE (2007)
Networks for the allosteric control of protein kinases
Zhengshuang Shi et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2006)
A critical assessment of docking programs and scoring functions
Gregory L. Warren et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Protein-ligand docking: Current status and future challenges
Sergio Filipe Sousa et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2006)
Identification of a lead small-molecule inhibitor of the Aurora kinases using a structure-assisted, fragment-based approach
Steven L. Warner et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Tyrosine kinase inhibitors of vascular endothelial growth factor receptors in clinical trials: Current status and future directions
Alessandro Morabito et al.
ONCOLOGIST (2006)
Development of quantitative structure-binding affinity relationship models based on novel geometrical chemical descriptors of the protein-ligand interfaces
SX Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Allosteric inhibitors of Bcr-abl-dependent cell proliferation
FJ Adrián et al.
NATURE CHEMICAL BIOLOGY (2006)
Physics-based scoring of protein-ligand complexes: Enrichment of known inhibitors in large-scale virtual screening
N Huang et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2006)
Coarse-grained normal mode analysis in structural biology
I Bahar et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2005)
Discovery and evaluation of 2-anilino-5-aryloxazoles as a novel class of VEGFR2 kinase inhibitors
PA Harris et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Comparative analysis of two clinically active BCR-ABL kinase inhibitors reveals the role of conformation-specific binding in resistance
MR Burgess et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening
TA Halgren et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF
PTC Wan et al.
CELL (2004)
Predicting protein-ligand binding affinities using novel geometrical descriptors and machine-learning methods
W Deng et al.
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES (2004)
Overriding imatinib resistance with a novel ABL kinase inhibitor
NP Shah et al.
SCIENCE (2004)
Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibition
JF Ohren et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2004)
Docking and scoring in virtual screening for drug discovery: Methods and applications
DB Kitchen et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
A biomolecular force field based on the free enthalpy of hydration and solvation: The GROMOS force-field parameter sets 53A5 and 53A6
C Oostenbrink et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
Improved protein-ligand docking using GOLD
ML Verdonk et al.
PROTEINS-STRUCTURE FUNCTION AND GENETICS (2003)
Structural basis for the autoinhibition of c-Abl tyrosine kinase
B Nagar et al.
CELL (2003)
The protein kinase complement of the human genome
G Manning et al.
SCIENCE (2002)
The consequences of translational and rotational entropy lost by small molecules on binding to proteins
CW Murray et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2002)
Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia
NP Shah et al.
CANCER CELL (2002)
Protein kinases - the major drug targets of the twenty-first century?
P Cohen
NATURE REVIEWS DRUG DISCOVERY (2002)
A review of protein-small molecule docking methods
RD Taylor et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2002)
Kinetic and catalytic mechanisms of protein kinases
JA Adams
CHEMICAL REVIEWS (2001)
Molecular complexity and its impact on the probability of finding leads for drug discovery
MM Hann et al.
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES (2001)
GRid-INdependent descriptors (GRIND): A novel class of alignment-independent three-dimensional molecular descriptors
M Pastor et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Share Paper
